Shareholder adviser Glass Lewis joins political retreat

Companies Reviewing GLP-1 Coverage Should Also Review Transgender Healthcare Coverage 

According to reports earlier this month, Starbucks is ending GLP-1 coverage for its employees. Under its new healthcare plan, Starbucks will no longer cover prescription drugs used for weight loss, but it will continue to cover comprehensive transgender healthcare interventions, including reconstructive surgical procedures and puberty blockers, for covered dependents. Employers are pulling back on GLP-1 coverage largely for the same reason they are reconsidering other benefits: to adjust to rising healthcare costs. RxBenefits reports that GLP-1 drugs cost roughly $1,000–$1,500 per month, while SHRM estimates employers often shoulder 70–100% of prescription drug costs.  With GLP-1s now accounting for around 20% of prescription drug spending and the number of users accelerating, employers face a limited set of choices: tighten eligibility requirements, shift more of the cost to employees or customers, or eliminate coverage altogether.  If companies can reasonably reconsider GLP-1 coverage because of cost, uncertain return on investment, and broader questions over what an employer-sponsored health plan should cover, why should other expensive medical benefits, such as transgender medical interventions, be exempt from similar scrutiny?  According to February 2026 data from the Human Rights Campaign, more than 550 major companies, including Starbucks, offer comprehensive transgender healthcare benefits to employees and covered dependents. While …

Microsoft Directs Benevity to Drop SPLC Filter

After engagement from Inspire Investing and others, Microsoft has directed Benevity to stop using the SPLC’s “hate map” to filter nonprofits from its employee gift-matching program. In its “Max the Match” document, Microsoft states any nonprofit organization that “verifies its 501c3 or equivalent status will be available to Microsoft employees.” The Daily Signal highlighted several organizations, including the 1792 Exchange, engaging companies on behalf of shareholders to ensure charitable giving is viewpoint neutral. The 1792 Exchange is pleased to work alongside Inspire Investing, Bowyer Research, the Heritage Foundation, and many others in this important work. 1792 Exchange created this resource to track how companies are responding to the growing controversy surrounding the SPLC and Benevity and encourages companies that have made changes to their charitable giving programs to disclose those changes to their customers and shareholders.

‘CULTURAL CORRECTION’: 10 Major Brands Dial Back the LGBTQ Pride

Knicks parade attendee who dumped trash on sidewalk identified as JPMorgan Chase DEI exec, promptly fired

How One Leftist Group Prevents Corporate Employees From Supporting Conservative Nonprofits

Jeanine Pirro’s Prosecutors Probe Big Banks for Alleged ‘Debanking’